Experimental Therapies

News

October 20, 2022

1 min read

Save

New genetic engineering company aims to develop neuroactive compounds from plants, fungi

Empyrean Neuroscience Inc. has announced its launch as a genetic engineering company dedicated to developing fungi- and plant-based therapeutics for the treatment of neuropsychiatric and neurologic disorders.